Home
About
News
Events
Shop
Directory
Contact Us
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
PsyNews.com
Home
About
News
Events
Shop
Directory
Contact Us
Home
Uncategorized
Uncategorized
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
atai Life Sciences Announces First Subject Dosed in the Phase 1 IV-to-Subcutaneous Bridging Study of PCN-101 (R-Ketamine)
atai Life Sciences Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Clinical Pipeline Highlights
atai Life Sciences Reports First Quarter 2023 Financial Results and Announces Pipeline Highlights and Updates
atai Life Sciences to Participate in Upcoming May Investor Conference
atai Life Sciences Presents Pharmacodynamic Data on GRX-917 in a Late Breaking Poster Presentation at the 2023 SOBP Annual Meeting
atai Life Sciences Announces Key Clinical Pipeline and Corporate Updates
atai Life Sciences to Participate in the Cowen 43rd Annual Health...
Expanding ketamine’s horizons for rare neurological disorders
atai Life Sciences Company GABA Therapeutics Announces Positive Final Results from...
atai Life Sciences Announces Results from Phase 2a Trial of PCN-101...
atai Life Sciences Announces Results from the Kures Therapeutics Phase 1...
atai Life Sciences Initiates Phase 2b proof-of-concept trial of RL-007 for...
The atai Fellowship Fund in Psychedelic Neuroscience Announces its First Cohort...
atai Life Sciences Reports Third Quarter 2022 Financial Results and Business...
atai Life Sciences Strengthens Leadership Team with Appointment of Dr. Sahil...
1
2
3
...
11
Page 1 of 11